Hubei Biocause Pharmaceutical Co., Ltd. announced on 24 April 2023 the final profit distribution proposal for 2022 as Cash dividend/10 shares (tax included): CNY 1.10000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 CNY | -4.41% | -9.30% | -31.34% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.34% | 1.33B | |
+12.68% | 80.02B | |
+8.08% | 50.2B | |
+6.58% | 49.81B | |
+21.35% | 46.42B | |
+14.00% | 42.09B | |
+24.78% | 40.35B | |
-1.50% | 28.58B | |
-8.87% | 26.95B | |
+25.68% | 26.09B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. Announces Final Profit Distribution Proposal for 2022